The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Van Oort Douglas M since 2011.
The trader's CIK number is 1518733.
At the time of the last reporting, Van Oort Douglas M was the Chairman and CEO of Neogenomics Inc. (stock ticker symbol NEO).
Also see all insider trading activities at Neogenomics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | NEO | 0 | $0 | 340,000 | $14,283,573 | 500,000 | $3,759,999 |
| 2019 | NEO | 0 | $0 | 187,500 | $4,515,000 | 472,527 | $3,378,568 |
| 2018 | NEO | 0 | $0 | 0 | $0 | 65,680 | $0 |
| 2017 | NEO | 0 | $0 | 0 | $0 | 200,000 | $342,000 |
| 2016 | NEO | 0 | $0 | 931,387 | $7,396,303 | 1,600,000 | $1,826,000 |
| 2011 | NEO | 21,666 | $28,799 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-11-12 | NEO | Option Ex | 121,248 | 7.52 | 911,784 |
| 2020-11-13 | NEO | Option Ex | 358,752 | 7.52 | 2,697,815 |
| 2020-11-12 | NEO | Sale | 121,248 | 42.18 | 5,114,240 |
| 2020-11-13 | NEO | Sale | 118,752 | 41.56 | 4,935,333 |
| 2020-11-16 | NEO | Option Ex | 20,000 | 7.52 | 150,400 |
| 2020-11-16 | NEO | Sale | 100,000 | 42.34 | 4,234,000 |
| 2019-11-19 | NEO | Sale | 187,500 | 24.08 | 4,515,000 |
| 2019-11-08 | NEO | Option Ex | 472,527 | 7.15 | 3,378,568 |
| 2018-05-25 | NEO | Option Ex | 65,680 | .00 | 0 |
| 2017-02-02 | NEO | Option Ex | 200,000 | 1.71 | 342,000 |
| 2016-05-25 | NEO | Option Ex | 600,000 | 1.71 | 1,026,000 |
| 2016-05-26 | NEO | Sale | 98,387 | 8.69 | 854,983 |
| 2016-05-27 | NEO | Sale | 383,000 | 8.74 | 3,347,420 |
| 2016-03-08 | NEO | Option Ex | 1,000,000 | .80 | 800,000 |
| 2016-03-08 | NEO | Sale | 290,000 | 7.19 | 2,085,100 |
| 2016-03-09 | NEO | Sale | 160,000 | 6.93 | 1,108,800 |
| 2011-09-15 | NGNM.OB | Buy | 2,500 | 1.14 | 2,849 |
| 2011-08-22 | NGNM.OB | Buy | 2,000 | 1.15 | 2,300 |
| 2011-08-05 | NGNM.OB | Buy | 2,456 | 1.27 | 3,131 |
| 2011-08-08 | NGNM.OB | Buy | 2,000 | 1.30 | 2,600 |
| 2011-06-13 | NGNM.OB | Buy | 2,500 | 1.35 | 3,375 |
| 2011-05-26 | NGNM.OB | Buy | 2,500 | 1.40 | 3,500 |
| 2011-05-17 | NGNM.OB | Buy | 1,110 | 1.40 | 1,554 |
| 2011-05-12 | NGNM.OB | Buy | 1,000 | 1.40 | 1,400 |
| 2011-05-10 | NGNM.OB | Buy | 600 | 1.40 | 840 |
| 2011-05-06 | NGNM.OB | Buy | 5,000 | 1.45 | 7,250 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Van Oort Douglas M (Chairman and CEO of Neogenomics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.